Inflammatory Alveolar Type 2 Cells in Chronic Obstructive Pulmonary Disease: Impairing or Improving Disease Outcome?

Forskningsoutput: Tidskriftsbidrag › Debate/Note/Editorial

Originalspråk	engelska
Sidor (från-till)	621-622
Antal sidor	2
Tidskrift	American Journal of Respiratory Cell and Molecular Biology
Volym	67
Nummer	6
DOI	https://doi.org/10.1165/rcmb.2022-0371ED
Status	Published - 2022

Ämnesklassifikation (UKÄ)

@article{722e6048a67147e993e429f49238c450,

title = "Inflammatory Alveolar Type 2 Cells in Chronic Obstructive Pulmonary Disease: Impairing or Improving Disease Outcome?",

author = "Pavan Prabhala and Mattias Magnusson",

year = "2022",

doi = "10.1165/rcmb.2022-0371ED",

language = "English",

volume = "67",

pages = "621--622",

journal = "American Journal of Respiratory Cell and Molecular Biology",

issn = "1044-1549",

publisher = "American Thoracic Society",

number = "6",

}

TY - JOUR

T1 - Inflammatory Alveolar Type 2 Cells in Chronic Obstructive Pulmonary Disease

T2 - Impairing or Improving Disease Outcome?

AU - Prabhala, Pavan

AU - Magnusson, Mattias

PY - 2022

Y1 - 2022

U2 - 10.1165/rcmb.2022-0371ED

DO - 10.1165/rcmb.2022-0371ED

M3 - Debate/Note/Editorial

C2 - 36223081

AN - SCOPUS:85148027459

SN - 1044-1549

VL - 67

SP - 621

EP - 622

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

IS - 6

ER -